Atrial electrophysiologic properties of patients with asymptomatic Wolff-Parkinson-White syndrome.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 3402462)

Published in Eur Heart J on May 01, 1988

Authors

A Michelucci1, L Padeletti, D Monizzi, M C Porciani, R Musante, V Cupelli, P Delise, D D'Este

Author Affiliations

1: Cardiology Units of Firenze, Italy.

Articles citing this

Electrophysiological evaluation of Wolff-Parkinson-White syndrome. Indian Pacing Electrophysiol J (2002) 0.75

Articles by these authors

Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace (1999) 1.76

Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol (1999) 1.68

Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J (2002) 1.59

Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm; a randomized study. Eur Heart J (2002) 1.52

Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. Europace (2010) 1.43

Modification of antegrade slow pathway is not crucial for successful catheter ablation of common atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol (1999) 1.38

Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res (2001) 1.26

Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol (1990) 1.14

Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J (2001) 1.09

Management of syncope referred urgently to general hospitals with and without syncope units. Europace (2003) 0.98

Locating industrial VOC sources with aircraft observations. Environ Pollut (2011) 0.96

Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence. Heart (2004) 0.94

Fibrillin-1 (FBN1) gene frameshift mutations in Marfan patients: genotype-phenotype correlation. Clin Genet (2001) 0.91

Effects of ischemia and reperfusion on QT dispersion during coronary angioplasty. Pacing Clin Electrophysiol (1996) 0.89

Effects of silica on human lung fibroblast in culture. Sci Total Environ (2001) 0.89

Fully automated solid-phase microextraction-fast gas chromatography-mass spectrometry method using a new ionic liquid column for high-throughput analysis of sarcosine and N-ethylglycine in human urine and urinary sediments. Anal Chim Acta (2011) 0.86

[Prevalence of arterial hypertension in the community. Experience of the province of Veneto]. G Ital Cardiol (1980) 0.85

Atrioventricular interval optimization in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements. Pacing Clin Electrophysiol (2000) 0.85

A major involvement of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene. J Mol Cell Cardiol (1997) 0.84

Blood pressure and metabolic profile after surgical menopause: comparison with fertile and naturally-menopausal women. J Hum Hypertens (2000) 0.84

Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study. Eur J Cancer Prev (2005) 0.84

Should stimulation therapy for congestive heart failure be combined with defibrillation backup? Am J Cardiol (2000) 0.83

Endogenous dopamine (DA) and DA2 receptors: a mechanism limiting excessive sympathetic-adrenal discharge in humans. J Clin Endocrinol Metab (1988) 0.83

Ambulatory blood pressure in mild hypertensive women taking oral contraceptives. A case-control study. Am J Hypertens (1995) 0.83

Relationship between age and anterograde refractoriness of the accessory pathway in Wolff-Parkinson-White patients. Cardiology (1989) 0.82

Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (1996) 0.82

Preliminary experience with the pH-triggered pacemaker. Pacing Clin Electrophysiol (1978) 0.81

Aging and atrial electrophysiologic properties in man. Int J Cardiol (1984) 0.80

[Evaluation of the impact of night-work on health in a population of workers in Tuscany]. G Ital Med Lav Ergon (2013) 0.80

Possible role of a ventricular conduction disturbance in the electrogenesis of the ECG-VCG signs of myocardial infarction. J Electrocardiol (1983) 0.80

[Hemodynamic research and physiopathologic remarks on "vibration angiopathy" with Raynaud's phenomenon (author's transl)]. Lav Um (1976) 0.79

Atrial fibrillation in athletes. Int J Sports Med (2012) 0.79

[Longitudinal study for assessing the efficacy of preventive measures in a population of health workers exposed to the risk of patient lifting]. G Ital Med Lav Ergon (2005) 0.79

[Evaluation of sinoatrial conduction time by recording the sinus node potential. Comparison with indirect methods of evaluation]. Arch Mal Coeur Vaiss (1982) 0.79

Structural abnormalities and not diastolic dysfunction are the earliest left ventricular changes in hypertension. HARVEST Study Group. Am J Hypertens (1998) 0.79

Evaluation of atrial vulnerability with transoesophageal stimulation in patients with atrioventricular junctional reentrant tachycardia. Comparison with patients with ventricular pre-excitation and with normal subjects. Eur Heart J (1995) 0.78

[The endocavitary and transesophageal electrophysiological findings in idiopathic atrial fibrillation]. G Ital Cardiol (1991) 0.78

Anaerobic threshold in runners and cyclists. J Sports Med Phys Fitness (1989) 0.78

Glycaemic fall after a glucose load. A population-based study. Nutr Metab Cardiovasc Dis (2009) 0.78

The role of left ventricular conduction in the electrogenesis of left ventricular hypertrophy. An electrophysiologic study in man. Circulation (1979) 0.78

Prevention of short term reversible chronic atrial fibrillation by permanent pacing at the triangle of Koch. J Interv Card Electrophysiol (2000) 0.78

The effects of atropine on sinoatrial conduction time directly measured from sinus node electrogram. A comparison with results furnished by indirect methods. Eur Heart J (1984) 0.78

Effects of atropine on atrial refractoriness and its dispersion in humans. Int J Clin Pharmacol Ther Toxicol (1984) 0.77

[Doppler tissue imaging: a new method in the study of diastolic function in left ventricular hypertrophy]. G Ital Cardiol (1999) 0.77

Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study. Heart (2001) 0.77

The effects of alcohol consumption on ambulatory blood pressure and target organs in subjects with borderline to mild hypertension. HARVEST Study Group. Am J Hypertens (1998) 0.77

Evidence for oxidative stress in plasma of patients with Marfan syndrome. Int J Cardiol (2010) 0.77

[Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension]. G Ital Cardiol (1992) 0.77

[Accelerated idioventricular rhythm wih isorhythmic A-V dissociation. An electrophysiological study (author's transl)]. G Ital Cardiol (1980) 0.77

Long-term follow-up after atrioventricular nodal ablation and pacing: low incidence of sudden cardiac death. Pacing Clin Electrophysiol (2000) 0.76

Respiratory risks in tunnel construction workers. Int J Immunopathol Pharmacol (2004) 0.76

Myocardial infarction without pain. A study of the sensory function of the upper limbs. Pain (1976) 0.76

Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension. J Hypertens (1995) 0.76

Atrial refractoriness and spontaneous or induced atrial fibrillation. Acta Cardiol (1982) 0.75

Electrophysiologic procedures and activation of the hemostatic system. Am Heart J (1999) 0.75

[The ST/HR slope and coronary stenoses]. G Ital Cardiol (1993) 0.75

Thromboembolism after atrioventricular node ablation and pacing: long term follow up. Heart (1999) 0.75

[Exposure to Anisakis simplex in the fishing industry: an emerging aspect in occupational medicine?]. Med Lav (2010) 0.75

[Dynamic geometry of the left ventricle: indices of rigidity and distensibility]. Boll Soc Ital Cardiol (1977) 0.75

Cardiac effects of clomipramine treatment. ECG and left ventricular systolic time intervals. Neuropsychobiology (1983) 0.75

Hemodynamic effects of nitroglycerin. Int J Clin Pharmacol Biopharm (1979) 0.75

[Comparison of Narula's technic of direct and estimated sinoatrial conduction at increasing rates in normal subjects]. Arch Mal Coeur Vaiss (1984) 0.75

An unusual PR interval alternans during 2:1 atrio-ventricular block. Pacing Clin Electrophysiol (1983) 0.75

[Arterial impedance in evaluating peripheral arteriopathy]. Boll Soc Ital Cardiol (1977) 0.75

Bioavailability of digoxin and beta-methyl-digoxin. J Int Med Res (1976) 0.75

Assessment of sinus node function in asymptomatic subjects with sinus bradycardia and in symptomatic patients with sino-atrial disease. Acta Cardiol (1979) 0.75

Long-term follow-up in children without heart disease with ventricular premature beats. Eur Heart J (1987) 0.75

Anterograde sinuatrial conduction evaluated by sinus node electrogram in atropine blocked retrograde atrial conduction. Int J Cardiol (1985) 0.75

[Study of cardiac excitation and conduction after administration of oxyfedrine. Preliminary observations]. Boll Soc Ital Cardiol (1977) 0.75

Effects of pharmacologic autonomic blockade on atrial electrophysiologic properties in normal subjects and in patients with sinus node disease. Int J Cardiol (1985) 0.75

Influence of current strength on excitability and conduction of human atrium and atrioventricular node. Cardiovasc Res (1986) 0.75

[Sino-atrial disease (sick sinus syndrome). II. Clinical and electrophysiological correlations]. Recenti Prog Med (1979) 0.75

[Hemodynamic effects of bunitrolol]. Boll Soc Ital Cardiol (1977) 0.75

The cardiac electrophysiological effects of nifedipine. Int J Clin Pharmacol Biopharm (1979) 0.75

[Shifting of the sinusal pacemaker induced by diagnostic electrostimulation]. Boll Soc Ital Cardiol (1979) 0.75

[Bradycardia and/or asymptomatic and symptomatic sinus dysrhythmias. Value and limitations of the functional indices adopted]. G Ital Cardiol (1979) 0.75

[Sino-atrial disease (sick sinus syndrome). I. Recent nosographic and electrophysiological diagnostic acquistions]. Recenti Prog Med (1979) 0.75

Concealed, bigeminal, interpolated A-V junctional (extrasystolic or parasystolic) complexes. Heart Lung (1980) 0.75

Effects of one year of physical training on borderline hypertension: an evaluation by bicycle ergometer exercise testing. J Cardiovasc Pharmacol (1986) 0.75

[Studies on the "sympathicotonic" orthostatic hypotension syndrome with bradycardia]. Boll Soc Ital Cardiol (1976) 0.75

[Protocol for the registration of the sinus node electrogram]. G Ital Cardiol (1983) 0.75

[Atrial refractoriness and its dispersion in different physiopathologic conditions]. G Ital Cardiol (1982) 0.75

Long-term favourable effect of nifedipine in primary pulmonary hypertension. Report of a case with hemodynamic evaluation after 3 and after 16 months and with clinical follow-up during 36 months. G Ital Cardiol (1985) 0.75

Reversible cardiomyopathy following chronic supraventricular tachycardia. Cardiologia (1988) 0.75

Intracardiac electrophysiologic study of dilazep in man. Int J Cardiol (1984) 0.75

[Retrograde conduction, uni-directional block and synchronization in carriers of the artificial pacemaker]. Boll Soc Ital Cardiol (1972) 0.75

Clinical electrophysiological effects of chronic administration of verapamil: the phenomenon of overdrive excitation of junctional pacemaker. Int J Clin Pharmacol Ther Toxicol (1984) 0.75

[The peripheral circulation in essential arterial hypertension]. Boll Soc Ital Cardiol (1977) 0.75